Announcement

Collapse
No announcement yet.

Endocr Res . Insulin Treatment May Not Be Associated with Increased Mortality in Patients with COVID-19 and Concurrent Diabetes

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Endocr Res . Insulin Treatment May Not Be Associated with Increased Mortality in Patients with COVID-19 and Concurrent Diabetes


    Endocr Res


    . 2021 Feb 26;1-2.
    doi: 10.1080/07435800.2021.1892748. Online ahead of print.
    Insulin Treatment May Not Be Associated with Increased Mortality in Patients with COVID-19 and Concurrent Diabetes


    Chia Siang Kow 1 , Syed Shahzad Hasan 2 3



    Affiliations

    Abstract

    Previous study reported that preadmission insulin treatment in patients with coronavirus disease 2019 (COVID-19) and concurrent diabetes was associated with a significantly increased odds of mortality. However, such association may be modified by possible baseline differences in glycemic control between insulin users and non-insulin users. Misinterpretation of the association between insulin treatment and mortality could lead to confusion in clinical practice and hospitalized patients with COVID-19 for whom insulin treatment is appropriately indicated may be omitted from such treatment. However, requirement for insulin during hospitalization for COVID-19 may be a marker of poor prognosis and as such could be used to identify patient population who require more aggressive treatments to prevent mortality.

    Keywords: COVID-19; HbA1c; diabetes; insulin; mortality.

Working...
X